
  
    
      
        Background_NNP
        Transection_NNP of_IN the_DT peripheral_JJ axons_NNS of_IN primary_JJ sensory_JJ
        neurons_NNS results_NNS in_IN profound_JJ alterations_NNS in_IN their_PRP$
        metabolism_NN ,_, regenerative_JJ capacity_NN ,_, survival_NN ,_, excitability_NN ,_,
        transmitter_NN function_NN and_CC sensitivity_NN to_TO diverse_JJ extrinsic_JJ
        and_CC intrinsic_JJ signals_NNS [_NN 1_CD 2_CD ]_NN ._. These_DT changes_NNS are_VBP
        contributed_VBN to_TO by_IN transcriptional_NN alterations_NNS triggered_VBN by_IN
        a_DT loss_NN of_IN trophic_JJ support_NN from_IN peripheral_JJ target_NN organs_NNS ,_,
        and_CC by_IN novel_NN signals_NNS generated_VBN at_IN the_DT injury_NN site_NN ._. The_DT
        transcriptional_NN changes_NNS lead_VBP both_DT to_TO adaptive_JJ responses_NNS ,_,
        such_JJ as_IN the_DT capacity_NN to_TO survive_VB the_DT injury_NN and_CC re-grow_JJ the_DT
        injured_VBN axon_NN ,_, and_CC maladaptive_JJ responses_NNS that_WDT can_MD lead_VB to_TO a_DT
        change_NN in_IN sensation_NN ,_, including_VBG the_DT generation_NN of_IN
        neuropathic_JJ pain_NN [_NN 3_CD 4_CD ]_NN ._.
        Measurements_NNP of_IN mRNA_NN and_CC protein_NN made_VBN in_IN many_JJ
        laboratories_NNS using_VBG diverse_JJ methodologies_NNS have_VBP identified_VBN
        approximately_RB 40_CD genes_NNS that_WDT are_VBP up-regulated_JJ and_CC 25_CD
        down-regulated_JJ after_IN peripheral_JJ nerve_NN injury_NN [_NN 3_CD 5_CD 6_CD ]_NN ._.
        These_DT regulated_VBN genes_NNS include_VBP members_NNS of_IN several_JJ classes_NNS :_: G_NNP
        protein_NN coupled_VBN receptors_NNS ,_, ligand-_NN and_CC voltage-gated_JJ ion_NN
        channels_NNS ,_, receptor_NN tyrosine_NN kinases_NNS ,_, growth_NN factors_NNS ,_,
        cytokines_NNS ,_, neuropeptides_NNS ,_, cell_NN cytoskeletal_NN genes_NNS ,_, cell_NN
        surface_NN /_NN extracellular_NN matrix_NN genes_NNS ,_, and_CC a_DT miscellaneous_JJ
        group_NN of_IN enzymes_NNS ._.
        We_PRP have_VBP now_RB used_VBN high-density_JJ rat_NN genome_NN oligonucleotide_NN
        microarrays_NNS to_TO analyze_VB changes_NNS in_IN gene_NN expression_NN at_IN an_DT
        early_JJ time_NN point_NN (_( 3_CD days_NNS )_) following_VBG a_DT peripheral_JJ nerve_NN
        injury_NN in_IN adult_NN rats_NNS ._. Oligonucleotide_NNP microarrays_NNS provide_VBP
        the_DT capacity_NN to_TO analyze_VB parallel_JJ changes_NNS in_IN many_JJ thousands_NNS
        of_IN genes_NNS ,_, and_CC have_VBP been_VBN used_VBN successfully_RB to_TO examine_VB
        expression_NN profile_NN changes_NNS in_IN many_JJ neuronal_NN and_CC
        non-neuronal_JJ systems_NNS [_NN 7_CD ]_NN including_VBG DRG_NNP neurons_NNS [_NN 8_CD 9_CD ]_NN ._.
        Studying_NNP the_DT effect_NN of_IN peripheral_JJ nerve_NN injury_NN on_IN gene_NN
        expression_NN profiles_NNS in_IN the_DT DRG_NNP offers_VBZ several_JJ advantages_NNS ._.
        The_DT DRG_NNP represents_VBZ a_DT dense_JJ collection_NN of_IN cell_NN bodies_NNS of_IN one_CD
        general_JJ class_NN of_IN neuron_NN ,_, the_DT primary_JJ sensory_JJ neuron_NN ._. The_DT
        lesion_NN has_VBZ a_DT uniform_NN impact_NN on_IN the_DT cells_NNS ,_, and_CC the_DT existence_NN
        of_IN a_DT large_JJ pool_NN of_IN genes_NNS with_IN known_VBN regulation_NN allows_VBZ for_IN
        quality_NN controls_NNS for_IN changes_NNS identified_VBN by_IN the_DT microarrays_NNS
        [_NN 3_CD 5_CD 6_CD ]_NN ._.
        Although_IN microarrray_NN technology_NN offers_VBZ enormous_JJ
        potential_JJ advantages_NNS ,_, there_EX remain_VB important_JJ concerns_NNS about_IN
        representation_NN ,_, sensitivity_NN ,_, reproducibility_NN ,_, variability_NN
        and_CC the_DT false_JJ positive_JJ and_CC negative_JJ detection_NN rates_NNS [_NN 10_CD 11_CD
        ]_NN ._. What_WP ,_, if_IN any_DT ,_, is_VBZ the_DT threshold_NN fold-difference_JJ between_IN
        probe_NN sets_NNS that_WDT reflects_VBZ real_JJ regulation_NN ?_. Is_VBZ
        fold-difference_JJ the_DT most_RBS sensitive_JJ measure_NN for_IN detecting_VBG
        changes_NNS ?_. Are_VBP genes_NNS with_IN a_DT low_JJ expression_NN levels_NNS in_IN all_DT
        conditions_NNS detected_VBD ?_. What_WP is_VBZ the_DT concordance_NN rate_NN between_IN
        genes_NNS identified_VBN as_IN regulated_VBN by_IN independent_JJ methods_NNS and_CC
        genes_NNS identified_VBN by_IN the_DT microarray_NN analysis_NN ?_. What_WP criteria_NNS
        need_VBP to_TO be_VB used_VBN to_TO jointly_RB minimize_VB the_DT false_JJ negative_JJ and_CC
        the_DT false_JJ positive_JJ rates_NNS ?_. How_WRB many_JJ arrays_NNS need_VBP to_TO be_VB
        analyzed_VBN ?_.
        We_PRP now_RB show_VBP that_IN fold-difference_JJ alone_RB results_VBZ in_IN a_DT high_JJ
        degree_NN of_IN error_NN whilst_NN detecting_VBG regulated_VBN genes_NNS from_IN
        microarrays_NNS ,_, replicate_VB arrays_NNS with_IN statistical_JJ analysis_NN
        reduces_VBZ false_JJ positives_NNS and_CC negatives_NNS ._. The_DT oligonucleotide_NN
        microarray_NN screen_NN indicates_VBZ that_IN hundreds_NNS of_IN genes_NNS are_VBP
        regulated_VBN by_IN neuronal_NN injury_NN ,_, and_CC that_IN this_DT technique_NN is_VBZ a_DT
        powerful_JJ primary_JJ screen_NN for_IN such_JJ changes_NNS ._.
      
      
        Results_NNS
        
          Array_NNP sensitivity_NN and_CC variability_NN
          Affymetrix_NNP rat_NN U_NNP 34_CD A_DT oligonucleotide_NN arrays_NNS were_VBD used_VBN
          to_TO screen_VB for_IN changes_NNS in_IN gene_NN expression_NN in_IN DRG_NNP neurons_NNS
          three_CD days_NNS following_VBG a_DT peripheral_JJ nerve_NN transection_NN
          (_( axotomy_NN ,_, Ax_NNP )_) by_IN comparing_VBG expression_NN levels_NNS with_IN
          non-injured_JJ DRGs_NNP (_( naïve_NN ,_, N_NNP )_) ._. Nine_CD biologically_RB
          independent_JJ array_NN hybridizations_NNS were_VBD performed_VBN (_( six_CD
          naïve_NN and_CC three_CD axotomy_NN )_) ._. DRG_NNP tissue_NN (_( L_NNP 4_CD and_CC L_NNP 5_CD from_IN the_DT
          left_NN or_CC ipsilateral_NN side_NN to_TO the_DT injury_NN )_) from_IN 5_CD male_JJ
          Sprague-_NNP Dawley_NNP rats_NNS were_VBD pooled_VBN for_IN each_DT RNA_NNP population_NN ._.
          Each_DT RNA_NNP sample_NN was_VBD labeled_VBN separately_RB and_CC hybridized_JJ to_TO
          a_DT separate_JJ array_NN ._. Genes_NNP were_VBD defined_VBN as_IN detected_VBN if_IN they_PRP
          received_VBD a_DT present_JJ or_CC marginal_JJ call_NN in_IN at_IN least_JJS one_CD of_IN
          the_DT arrays_NNS within_IN each_DT comparison_NN ._. Of_IN the_DT 8799_CD annotated_JJ
          genes_NNS and_CC expressed_VBD sequence_NN tags_NNS (_( ESTs_NNP )_) represented_VBD on_IN
          the_DT rat_NN U_NNP 34_CD A_DT array_NN ,_, 52_CD %_NN (_( n_NN =_SYM 6_CD ,_, naïve_NN arrays_NNS )_) were_VBD
          detected_VBN in_IN arrays_NNS hybridized_JJ with_IN naïve_NN rat_NN DRG_NNP cRNA_NN and_CC
          54_CD %_NN (_( n_NN =_SYM 3_CD ,_, axotomy_NN arrays_NNS )_) genes_NNS in_IN the_DT axotomy_NN
          comparisons_NNS ._.
          To_TO assess_VB the_DT degree_NN of_IN variability_NN inherent_JJ in_IN the_DT
          system_NN ,_, the_DT mean_JJ probe_NN set_VBD intensity_NN values_NNS of_IN the_DT two_CD
          independent_JJ sets_NNS of_IN three_CD naïve_NN samples_NNS were_VBD compared_VBN on_IN
          a_DT scatter_NN plot_NN (_( Figure_NN 1_CD A_DT )_) ._. The_DT majority_NN of_IN probe_NN sets_NNS
          from_IN the_DT two_CD control_NN groups_NNS (_( N_NNP vs_NNS ._. N_NNP )_) lie_VB on_IN or_CC very_RB
          close_RB to_TO the_DT identity_NN line_NN ,_, with_IN a_DT linear_JJ regression_NN of_IN r_LS
          2_CD =_SYM 0_CD ._. 9898_CD (_( for_IN all_DT detected_VBN genes_NNS in_IN the_DT N_NNP vs_NNS ._. N_NNP
          comparison_NN ,_, Figure_NN 1_CD A_DT )_) ._. Figure_NN 1_CD Ashows_NNP that_IN most_JJS of_IN the_DT
          variation_NN between_IN the_DT two_CD naïve_NN groups_NNS exists_VBZ at_IN the_DT
          lower_JJR end_NN of_IN the_DT gene_NN expression_NN levels_NNS ._. This_DT suggests_VBZ
          that_IN this_DT variability_NN is_VBZ in_IN part_NN due_JJ to_TO array_NN
          sensitivity_NN ._. In_IN consequence_NN ,_, differences_NNS in_IN low_JJ intensity_NN
          genes_NNS may_MD be_VB unreliable_JJ ._.
          A_DT plot_NN of_IN the_DT mean_JJ intensity_NN from_IN triplicate_NN naives_NNS
          against_IN triplicate_NN 3_CD day_NN axotomy_NN (_( N_NNP vs_NNS ._. Ax_NNP )_) arrays_NNS
          (_( Figure_NN 1_CD B_NNP )_) show_NN many_JJ data_NNS points_NNS lying_VBG both_DT above_IN and_CC
          below_IN the_DT identity_NN line_NN ,_, suggesting_VBG regulation_NN ._. Since_IN
          each_DT individual_JJ sample_NN was_VBD pooled_VBN from_IN 5_CD male_JJ
          Sprague-_NNP Dawley_NNP animals_NNS of_IN a_DT similar_JJ age_NN and_CC from_IN a_DT single_JJ
          supplier_NN (_( Charles_NNP River_NNP )_) ,_, biological_JJ variation_NN is_VBZ likely_JJ
          to_TO be_VB minimal_JJ ._.
        
        
          Defining_VBG regulated_VBN genes_NNS
          Many_JJ of_IN the_DT detected_VBN genes_NNS in_IN both_DT the_DT N_NNP vs_NNS ._. N_NNP and_CC the_DT
          N_NNP vs_NNS ._. Ax_NNP array_NN comparison_NN groups_NNS show_VBP no_DT difference_NN ,_,
          defined_VBN as_IN fold-difference_JJ up_RB or_CC down_IN less_RBR than_IN 1_CD ._. 15_CD
          (_( 69_CD %_NN ,_, N_NNP vs_NNS ._. N_NNP and_CC 47_CD %_NN ,_, N_NNP vs_NNS ._. Ax_NNP )_) (_( Figure_NN 1_CD E_NNP )_) ._. Further_RB ,_,
          many_JJ show_NN small_JJ fold-differences_JJ of_IN 1_CD ._. 15_CD to_TO 1_CD ._. 5_CD (_( 27_CD %_NN ,_, N_NNP
          vs_NNS ._. N_NNP and_CC 41_CD %_NN ,_, N_NNP vs_NNS ._. Ax_NNP )_) (_( Figure_NN 1_CD E_NNP )_) ._. In_IN total_JJ ,_, genes_NNS
          displaying_VBG a_DT fold-difference_JJ below_IN 1_CD ._. 5_CD -_: fold_VB accounted_VBN for_IN
          97_CD %_NN of_IN the_DT N_NNP vs_NNS ._. N_NNP arrays_NNS and_CC 88_CD %_NN of_IN the_DT N_NNP vs_NNS ._. Ax_NNP
          comparison_NN ._.
          When_WRB statistical_JJ significance_NN is_VBZ not_RB taken_VBN into_IN
          account_NN ,_, 122_CD genes_NNS display_VBP a_DT difference_NN of_IN 1_CD ._. 5_CD -_: 2_CD ._. 0_CD fold_VB
          and_CC 28_CD a_DT greater_JJR than_IN 2_CD -_: fold_VB difference_NN in_IN the_DT N_NNP vs_NNS ._. N_NNP
          group_NN (_( 2_CD ._. 6_CD %_NN and_CC 0_CD ._. 6_CD %_NN of_IN present_JJ genes_NNS respectively_RB )_) ._. In_IN
          the_DT N_NNP vs_NNS ._. Ax_NNP group_NN 369_CD genes_NNS show_VBP a_DT fold-difference_JJ of_IN
          1_CD ._. 5_CD -_: 2_CD ._. 0_CD and_CC 178_CD greater_JJR than_IN 2_CD -_: fold_VB (_( 7_CD ._. 8_CD %_NN and_CC 3_CD ._. 8_CD %_NN of_IN
          present_JJ genes_NNS respectively_RB )_) ._. Although_IN a_DT greater_JJR than_IN
          2_CD -_: fold_VB change_NN cut_NN off_RP eliminates_VBZ most_RBS false_JJ positives_NNS
          (_( estimated_VBN error_NN rate_NN ,_, 16_CD %_NN )_) ,_, this_DT specificity_NN is_VBZ at_IN the_DT
          expense_NN of_IN many_JJ putatively_RB regulated_VBN genes_NNS ._. In_IN the_DT
          1_CD ._. 5_CD -_: 2_CD ._. 0_CD fold_VB range_NN in_IN the_DT N_NNP vs_NNS ._. Ax_NNP group_NN ,_, there_EX are_VBP still_RB
          three_CD times_NNS as_IN many_JJ genes_NNS as_IN are_VBP in_IN the_DT N_NNP vs_NNS ._. N_NNP group_NN ._.
          (_( 369_CD genes_NNS [_NN N_NNP vs_NNS ._. Ax_NNP ]_NN vs_NNS ._. 122_CD genes_NNS [_NN N_NNP vs_NNS ._. N_NNP ]_NN ;_: Figure_NN
          1_CD E_NNP )_) ._.
          In_IN order_NN to_TO distinguish_VB systematic_JJ from_IN random_JJ
          differences_NNS in_IN the_DT array_NN intensity_NN levels_NNS ,_, a_DT two-tailed_JJ
          t-test_JJ was_VBD performed_VBN for_IN both_DT comparison_NN groups_NNS ,_, which_WDT
          was_VBD possible_JJ since_IN each_DT group_NN consisted_VBD of_IN three_CD
          independent_JJ experiments_NNS ._. One_CD of_IN the_DT fundamental_JJ problems_NNS
          in_IN analyzing_VBG microarray_NN data_NNS is_VBZ the_DT risk_NN of_IN false_JJ
          positive_JJ results_NNS due_JJ to_TO multiple_JJ hypothesis_NNS testing_NN ._. The_DT
          most_RBS conservative_JJ approach_NN to_TO this_DT problem_NN ,_, a_DT
          Bonferroni-corrected_NNP significance_NN threshold_NN ,_, would_MD not_RB
          result_VB in_IN any_DT significantly_RB regulated_VBN genes_NNS ,_, as_IN the_DT
          adjusted_VBN threshold_NN would_MD be_VB 1_CD ._. 06_CD ×_NN 10_CD -_: 5_CD ,_, while_IN the_DT
          lowest_JJS P_NN value_NN attained_VBN in_IN our_PRP$ data_NNS set_VBN for_IN the_DT N_NNP vs_NNS ._. Ax_NNP ._.
          comparison_NN was_VBD 1_CD ._. 51_CD ×_NN 10_CD -_: 5_CD ._. This_DT would_MD also_RB rule_VB out_IN
          identification_NN of_IN genes_NNS via_IN step-down_JJ methods_NNS based_VBN on_IN
          the_DT Bonferroni_NNP correction_NN ._. Therefore_RB ,_, we_PRP attempted_VBD to_TO
          assess_VB the_DT accumulation_NN of_IN false_JJ positives_NNS empirically_RB ,_,
          by_IN testing_VBG multiple_JJ hypotheses_NNS in_IN our_PRP$ system_NN on_IN a_DT sample_NN
          not_RB expected_VBD to_TO include_VB any_DT true_JJ positives_NNS ,_, i_NNP ._. e_SYM ._. the_DT N_NNP ._.
          vs_NNS ._. N_NNP ._. comparison_NN ._. Those_DT probe_NN sets_NNS with_IN a_DT unadjusted_JJ
          significance_NN of_IN P_NN <_NN 0_CD ._. 05_CD (_( blue_JJ )_) ,_, P_NN <_NN 0_CD ._. 01_CD (_( green_JJ )_)
          or_CC P_NN <_NN 0_CD ._. 001_CD (_( red_JJ )_) are_VBP indicated_VBN on_IN the_DT scatter_NN plots_NNS
          in_IN Figures_NNS 1_CD Cand_NNP 1_CD D_NNP ,_, while_IN the_DT distribution_NN of_IN
          significant_JJ differences_NNS at_IN different_JJ fold-changes_JJ is_VBZ
          illustrated_VBN in_IN the_DT table_NN in_IN Figure_NN 1_CD E_NNP ._. Of_IN the_DT 4599_CD
          detected_VBD genes_NNS in_IN the_DT naïve_NN samples_NNS ,_, 109_CD show_NN a_DT
          significant_JJ difference_NN between_IN the_DT two_CD sets_NNS (_( 2_CD ._. 4_LS %_NN ,_, P_NN <_NN
          0_CD ._. 05_CD )_) ._. The_DT vast_JJ majority_NN of_IN these_DT genes_NNS ,_, however_RB ,_, exhibit_NN
          low_JJ fold_VB changes_NNS (_( <_NN 1_CD ._. 5_LS -_: fold_VB ,_, 89_CD %_NN ,_, Figure_NN 1_CD E_NNP )_) ._.
          Of_IN the_DT 369_CD genes_NNS that_WDT show_NN a_DT fold-difference_JJ of_IN
          1_CD ._. 5_CD -_: 2_CD ._. 0_CD and_CC the_DT 178_CD that_WDT were_VBD above_IN 2_CD -_: fold_VB in_IN the_DT N_NNP vs_NNS ._.
          Ax_NNP comparison_NN ,_, 223_CD (_( 60_CD %_NN )_) and_CC 84_CD (_( 57_CD %_NN )_) respectively_RB were_VBD
          not_RB significant_JJ (_( Figure_NN 1_CD E_NNP ,_, P_NN <_NN 0_CD ._. 05_CD )_) ._. These_DT data_NNS
          indicate_VBP that_IN using_VBG a_DT fold-difference_JJ of_IN greater_JJR than_IN 2_CD
          from_IN triplicate_NN samples_NNS to_TO select_VB regulated_VBN genes_NNS will_MD
          include_VB many_JJ false_JJ positives_NNS ._. However_RB ,_, combining_VBG fold_VB
          difference_NN with_IN significant_JJ difference_NN in_IN a_DT two_CD
          dimensional_NN matrix_NN can_MD reduce_VB the_DT false_JJ positive_JJ error_NN
          rate_NN drastically_RB ._. The_DT combination_NN of_IN a_DT >_NN 1_CD ._. 5_LS -_: fold_VB and_CC
          significant_JJ difference_NN (_( P_NN <_NN 0_CD ._. 05_CD )_) identifies_VBZ 12_CD genes_NNS
          in_IN the_DT N_NNP vs_NNS ._. N_NNP comparison_NN compared_VBN with_IN 240_CD genes_NNS for_IN N_NNP
          vs_NNS ._. Ax_NNP ,_, a_DT 20_CD -_: fold_VB difference_NN (_( Figure_NN 1_CD E_NNP )_) ._. The_DT estimated_VBN
          error_NN of_IN 5_CD %_NN using_VBG these_DT two_CD criteria_NNS is_VBZ much_RB less_JJR than_IN
          that_DT obtained_VBD using_VBG just_RB above_IN 2_CD -_: fold_VB (_( 16_CD %_NN )_) or_CC
          significance_NN alone_RB (_( 20_CD %_NN )_) and_CC prevents_VBZ many_JJ genes_NNS
          regulated_VBN below_IN 2_CD -_: fold_VB being_VBG excluded_VBN from_IN consideration_NN
          of_IN regulation_NN ._.
          The_DT inherent_JJ array_NN error_NN rate_NN (_( determined_VBN by_IN the_DT
          significant_JJ difference_NN rate_NN in_IN the_DT N_NNP vs_NNS ._. N_NNP analysis_NN )_) is_VBZ
          clustered_VBN at_IN low_JJ fold_VB changes_NNS (_( Figure_NN 1_CD E_NNP )_) ._. However_RB ,_, many_JJ
          more_JJR genes_NNS achieve_VBP statistical_JJ significance_NN at_IN these_DT
          small_JJ fold_VB changes_NNS in_IN the_DT N_NNP vs_NNS ._. Ax_NNP comparison_NN than_IN in_IN the_DT
          N_NNP vs_NNS ._. N_NNP group_NN (_( 1_CD ._. 15_CD -_: 1_CD ._. 5_LS fold_VB :_: 6_CD ._. 2_CD %_NN [_NN N_NNP vs_NNS ._. Ax_NNP ]_NN and_CC 1_CD ._. 9_CD %_NN [_NN N_NNP
          vs_NNS ._. N_NNP ]_NN ;_: Figure_NN 1_CD E_NNP )_) indicating_VBG that_IN some_DT low_JJ fold_VB
          differences_NNS may_MD be_VB real_JJ ._. The_DT degree_NN of_IN significance_NN (_( P_NN
          <_NN 0_CD ._. 001_CD ;_: 0_CD ._. 01_CD ,_, 0_CD ._. 05_CD )_) helps_VBZ distinguish_VB erroneous_JJ
          changes_NNS at_IN these_DT low_JJ fold_VB levels_NNS (_( Figure_NN 1_CD E_NNP )_) ._.
        
        
          Comparison_NNP of_IN array_NN data_NNS with_IN the_DT literature_NN
          Table_NNP 1_CD (_( see_VB additional_JJ file_NN 1_LS )_) lists_NNS those_DT genes_NNS
          previously_RB shown_VBN to_TO be_VB regulated_VBN in_IN various_JJ sciatic_JJ nerve_NN
          injury_NN models_NNS using_VBG a_DT variety_NN techniques_NNS ,_, as_RB well_RB as_IN the_DT
          expression_NN intensity_NN ,_, fold_VB change_NN and_CC P_NN value_NN derived_VBN for_IN
          these_DT genes_NNS from_IN the_DT arrays_NNS ._. Of_IN 69_CD genes_NNS reported_VBD in_IN the_DT
          literature_NN to_TO be_VB expressed_VBN in_IN the_DT DRG_NNP (_( Table_NNP 1_CD ,_, see_VBP
          additional_JJ file_NN 1_LS )_) 16_CD are_VBP not_RB detected_VBN by_IN the_DT arrays_NNS
          indicating_VBG that_DT array_NN sensitivity_NN is_VBZ an_DT issue_NN ._. Amongst_NNP
          these_DT are_VBP particular_JJ functional_JJ classes_NNS ,_, i_NNP ._. e_SYM ._. such_JJ as_IN G_NNP
          protein_NN coupled_VBN receptors_NNS ,_, which_WDT are_VBP expressed_VBN at_IN low_JJ
          levels_NNS [_NN 12_CD ]_NN ._.
          Additional_JJ File_NNP 1_CD
          Comparison_NNP of_IN microarray_NN and_CC known_VBN regulation_NN data_NNS for_IN
          genes_NNS whose_WP$ expression_NN pattern_NN within_IN the_DT DRG_NNP following_VBG
          nerve_NN injury_NN has_VBZ been_VBN studied_VBN previously_RB ._.
          Click_NNP here_RB for_IN file_NN
          25_CD of_IN the_DT 53_CD detected_VBD genes_NNS matched_VBD the_DT criteria_NNS
          (_( >_NN 1_CD ._. 5_LS -_: fold_VB ,_, P_NN <_NN 0_CD ._. 05_CD )_) for_IN defining_VBG regulated_VBN genes_NNS
          across_IN the_DT N_NNP vs_NNS ._. Ax_NNP comparison_NN ,_, and_CC all_DT of_IN these_DT were_VBD
          concordant_NN with_IN the_DT changes_NNS reported_VBD in_IN the_DT literature_NN
          (_( Table_NNP 1_CD ,_, see_VBP additional_JJ file_NN 1_LS )_) ._. In_IN addition_NN 4_CD of_IN the_DT 53_CD
          detected_VBD genes_NNS whose_WP$ levels_NNS had_VBD previously_RB been_VBN described_VBN
          as_IN unchanged_JJ by_IN axotomy_NN also_RB did_VBD not_RB vary_VB on_IN the_DT arrays_NNS ._.
          Mismatches_NNP between_IN changes_NNS expected_VBN from_IN the_DT literature_NN
          and_CC the_DT arrays_NNS may_MD be_VB due_JJ to_TO a_DT failure_NN of_IN small_JJ
          differences_NNS to_TO achieve_VB statistical_JJ significance_NN when_WRB
          using_VBG a_DT triplicate_NN analysis_NN ._. Furthermore_RB ,_, differences_NNS in_IN
          the_DT timing_NN ,_, the_DT nature_NN of_IN the_DT injury_NN models_NNS used_VBN and_CC
          detection_NN methods_NNS employed_VBN between_IN this_DT and_CC earlier_JJR
          studies_NNS make_VBP detailed_JJ analysis_NN of_IN these_DT data_NNS unfeasible_JJ ._.
          In_IN order_NN to_TO detect_VB true_JJ false_JJ positive_JJ and_CC negative_JJ rates_VBZ
          a_DT direct_JJ comparison_NN needs_VBZ to_TO be_VB made_VBN between_IN the_DT array_NN
          data_NN set_VBN and_CC transcript_NN levels_NNS measured_VBN in_IN samples_NNS
          equivalent_JJ to_TO those_DT used_VBN for_IN array_NN hybridization_NN ._.
        
        
          Northern_NNP blotting_VBG validation_NN of_IN transcriptional_NN
          regulation_NN
          Twenty_CD four_CD genes_NNS detected_VBN by_IN the_DT arrays_NNS as_IN being_VBG
          present_JJ in_IN the_DT DRG_NNP and_CC displaying_VBG up-_NN ,_, down-_NN or_CC no_DT
          regulation_NN three_CD days_NNS after_IN sciatic_JJ nerve_NN axotomy_NN were_VBD
          analyzed_VBN by_IN replicate_VB quantitative_JJ slot_NN blot_NN (_( Figure_NN 2_LS )_)
          and_CC Northern_NNP blot_NN analysis_NN (_( Figure_NN 3_LS )_) ._. The_DT genes_NNS were_VBD
          chosen_VBN in_IN a_DT non-random_JJ fashion_NN to_TO encompass_VB the_DT range_NN of_IN
          hybridization_NN intensities_NNS seen_VBN on_IN the_DT arrays_NNS ,_, with_IN
          expression_NN levels_NNS less_JJR than_IN 1000_CD to_TO intensity_NN levels_NNS
          greater_JJR than_IN 10_CD ,_, 000_CD ._. Genes_NNP were_VBD also_RB chosen_VBN which_WDT
          displayed_VBD a_DT wide_JJ range_NN of_IN fold-changes_JJ and_CC varying_VBG p_NN
          values_NNS and_CC possible_JJ functions_NNS were_VBD taken_VBN into_IN account_NN
          (_( Table_NNP 2_LS )_) ._.
          Figure_NN 2_CD illustrates_VBZ representative_NN triplicate_NN slot_NN
          blots_NNS for_IN three_CD genes_NNS with_IN altered_VBN expression_NN ,_, 2_CD showing_VBG
          an_DT increase_NN after_IN axotomy_NN (_( Figure_NN 2_CD Aand_NNP 2_CD B_NNP )_) and_CC one_CD a_DT
          decrease_NN (_( Figure_NN 2_CD C_NNP )_) ._. Cyclophilin_NNP ,_, a_DT gene_NN known_VBN not_RB to_TO
          alter_VB following_VBG axotomy_NN [_NN 13_CD ]_NN ,_, was_VBD used_VBN to_TO correct_VB for_IN
          loading_NN (_( Figure_NN 2_CD D_NNP )_) ._. Each_DT blot_NN was_VBD prepared_VBN from_IN
          independent_JJ L_NNP 4_CD and_CC L_NNP 5_CD DRG_NNP RNA_NNP samples_NNS extracted_VBN from_IN
          different_JJ groups_NNS of_IN animals_NNS than_IN those_DT used_VBN for_IN the_DT
          arrays_NNS ._.
          Triplicate_NNP slot_NN blots_NNS were_VBD produced_VBN for_IN all_DT 24_CD genes_NNS
          present_JJ in_IN Table_NNP 2_CD ._. The_DT concordance_NN rate_NN between_IN the_DT
          microarray_NN and_CC slot_NN blot_NN fold_VB changes_NNS for_IN the_DT 24_CD genes_NNS
          was_VBD 83_CD %_NN overall_NN but_CC concordance_NN depended_VBD on_IN gene_NN
          expression_NN level_NN (_( Table_NNP 2_LS )_) ._. Genes_NNP expressed_VBD at_IN low_JJ levels_NNS
          in_IN the_DT arrays_NNS tended_VBD to_TO display_VB fold_VB changes_NNS that_WDT varied_VBD
          from_IN that_DT found_VBN by_IN the_DT slot_NN blots_NNS ._. It_PRP is_VBZ likely_JJ that_IN this_DT
          is_VBZ a_DT consequence_NN of_IN the_DT unreliable_JJ average_NN intensity_NN
          estimation_NN for_IN low_JJ level_NN genes_NNS due_JJ to_TO limited_JJ array_NN
          sensitivity_NN (_( Figure_NN 1_CD A_DT )_) ._. If_IN genes_NNS with_IN a_DT mean_JJ intensity_NN
          expression_NN level_NN of_IN less_JJR than_IN 1000_CD are_VBP removed_VBN from_IN the_DT
          analysis_NN (_( top_JJ five_CD rows_NNS ,_, Table_NNP 2_LS )_) ,_, and_CC the_DT array_NN fold_VB
          changes_NNS of_IN the_DT remaining_VBG 19_CD genes_NNS are_VBP plotted_VBD against_IN the_DT
          slot_NN blot_NN fold_VB changes_NNS ,_, a_DT very_RB strong_JJ correlation_NN is_VBZ
          evident_JJ (_( linear_JJ regression_NN r_LS 2_CD =_SYM 0_CD ._. 8567_CD )_) (_( Figure_NN 2_CD E_NNP )_) ._. The_DT
          concordance_NN rate_NN of_IN this_DT group_NN is_VBZ 95_CD %_NN (_( using_VBG
          >_NN 1_CD ._. 5_LS -_: fold_VB ,_, P_NN <_NN 0_CD ._. 05_CD to_TO predict_VB regulation_NN )_) ._. This_DT
          shows_VBZ that_IN within_IN the_DT bounds_NNS of_IN array_NN sensitivity_NN ,_,
          average_JJ fold_VB changes_NNS for_IN genes_NNS found_VBD to_TO differ_VB
          significantly_RB between_IN triplicate_NN control_NN and_CC experimental_JJ
          arrays_NNS represent_VBP a_DT reasonable_JJ estimate_NN of_IN the_DT relative_JJ
          changes_NNS in_IN gene_NN expression_NN ._.
          Northern_JJ blot_NN analysis_NN ,_, although_IN requiring_VBG more_JJR
          tissue_NN ,_, both_DT confirms_VBZ that_IN the_DT correct_JJ transcript_NN size_NN is_VBZ
          recognized_VBN by_IN the_DT probe_NN and_CC enables_VBZ splice_NN variants_NNS to_TO be_VB
          identified_VBN (_( Figure_NN 3_LS )_) ._. All_DT 24_CD genes_NNS in_IN Table_NNP 2_CD were_VBD
          analyzed_VBN in_IN this_DT way_NN and_CC alternate_JJ splice_NN forms_NNS were_VBD
          evident_JJ for_IN 5_CD genes_NNS ._.
          A_DT list_NN of_IN all_PDT the_DT putatively_RB regulated_VBN genes_NNS within_IN
          the_DT DRG_NNP detected_VBN by_IN the_DT arrays_NNS (_( >_NN 1_CD ._. 5_LS -_: fold_VB and_CC P_NN <_NN
          0_CD ._. 05_CD )_) 3_CD days_NNS following_VBG a_DT sciatic_JJ nerve_NN transection_NN are_VBP
          given_VBN as_IN additional_JJ data_NNS in_IN table_NN 3_CD (_( see_VB additional_JJ file_NN
          2_LS )_) ._.
          Additional_JJ File_NNP 2_CD
          Summary_NNP of_IN genes_NNS identified_VBN as_IN regulated_VBN >_NN 1_CD ._. 5_LS -_: fold_VB
          (_( P_NN <_NN 0_CD ._. 05_CD )_) in_IN the_DT DRG_NNP 3_CD days_NNS after_IN sciatic_JJ nerve_NN
          axotomy_NN ._.
          Click_NNP here_RB for_IN file_NN
        
        
          In_IN situHybridization_NN
          Dorsal_NNP root_NN ganglia_NN as_RB well_RB as_IN containing_VBG the_DT cell_NN
          bodies_NNS of_IN primary_JJ sensory_JJ neurons_NNS also_RB contain_VBP satellite_NN
          glial_NN cells_NNS ,_, Schwann_NNP cells_NNS and_CC immune_JJ cells_NNS and_CC it_PRP is_VBZ
          important_JJ ,_, therefore_RB to_TO determine_VB which_WDT of_IN these_DT cell_NN
          types_NNS express_VBP the_DT regulated_VBN genes_NNS ._. Here_RB we_PRP use_VBP isotopic-_NN 
          in_IN situ_NN hybridization_NN (_( ISH_NNP )_) to_TO
          determine_VB the_DT cellular_JJ localization_NN of_IN 6_CD transcripts_NNS
          (_( Figure_NN 4_LS )_) ._. All_DT genes_NNS selected_VBN are_VBP neuronal_NN ._. GTPcylo_NNP ,_,
          IES-JE_NNP ,_, CCHL_NNP 2_CD A_DT and_CC VGF_NNP all_DT show_NN a_DT marked_VBN increase_NN in_IN the_DT
          number_NN of_IN labeled_VBN neurons_NNS while_IN SNAP_NNP 25_CD and_CC the_DT 5_CD HT_NNP 3_CD
          receptor_NN show_NN a_DT decrease_NN in_IN numbers_NNS and_CC intensity_NN of_IN
          labeled_VBN DRG_NNP neurons_NNS following_VBG axotomy_NN (_( Figure_NN 4_LS )_) ._.
        
        
          Time_NNP dependent_JJ changes_NNS in_IN transcription_NN
          The_DT pattern_NN of_IN expression_NN of_IN four_CD genes_NNS within_IN the_DT DRG_NNP
          (_( Lysozyme_NNP ,_, PACAP_NNP ,_, MET-_NNP 1_CD and_CC SNAP_NNP 25_CD )_) were_VBD further_RBR
          quantified_VBN across_IN a_DT time_NN course_NN of_IN 1_CD ,_, 3_CD ,_, 7_CD and_CC 14_CD days_NNS
          post_NN axotomy_NN by_IN triplicate_NN northern_JJ slot_NN blot_NN (_( Figure_NN 5_LS )_) ._.
          These_DT genes_NNS show_VBP diverse_JJ patterns_NNS of_IN regulation_NN ._. While_IN
          lysozyme_NN ,_, PACAP_NNP ,_, MET-_NNP 1_CD are_VBP all_DT up-regulated_JJ ,_, for_IN MET_NNP 1_CD
          this_DT is_VBZ only_RB transient_JJ ._. Identical_NNP results_NNS were_VBD found_VBN by_IN
          in_IN situ_NN hybridization_NN (_( Fig_NNP ._. 4_LS )_) ._. Profiling_NNP changes_NNS in_IN
          transcription_NN over_IN time_NN is_VBZ therefore_RB ,_, important_JJ ._.
        
        
          Potential_JJ roles_NNS of_IN injury-regulated_JJ genes_NNS
          Table_NNP 4_CD (_( see_VB additional_JJ file_NN 3_LS )_) indicates_VBZ the_DT pattern_NN
          of_IN expression_NN ,_, class_NN ,_, action_NN ,_, and_CC functional_JJ role_NN for_IN 15_CD
          previously_RB uncharacterized_JJ ,_, and_CC 9_CD novel_NN injury-regulated_JJ
          genes_NNS ,_, amongst_IN the_DT 24_CD validated_JJ genes_NNS ._. Five_CD of_IN these_DT
          genes_NNS have_VBP been_VBN reported_VBN in_IN DRG_NNP neurons_NNS previously_RB and_CC
          six_CD of_IN the_DT genes_NNS are_VBP expressed_VBN in_IN PC_NN 12_CD cells_NNS ,_, a_DT
          pheochromocytoma-derived_JJ cell_NN line_NN that_IN shares_NNS neural_NN
          crest_NN origin_NN with_IN neurons_NNS of_IN the_DT DRG_NNP ._. Two_CD genes_NNS are_VBP
          expressed_VBN in_IN macrophages_NNS and_CC 6_CD in_IN glial_NN cells_NNS ._. Three_CD
          genes_NNS have_VBP been_VBN reported_VBN to_TO show_VB axotomy-induced_JJ
          regulation_NN in_IN non-_NN DRG_NNP neurons_NNS (_( sympathetic_JJ and_CC motor_NN
          neurons_NNS )_) ._. These_DT genes_NNS belong_VBP to_TO several_JJ different_JJ
          functional_JJ classes_NNS and_CC from_IN what_WP is_VBZ known_VBN about_IN their_PRP$
          functional_JJ role_NN in_IN other_JJ cells_NNS ,_, may_MD have_VB a_DT role_NN in_IN
          regeneration_NN ,_, cell_NN survival_NN ,_, or_CC alterations_NNS in_IN sensory_JJ
          processing_NN after_IN nerve_NN injury_NN (_( Table_NNP 4_CD ,_, see_VBP additional_JJ
          file_NN 3_LS )_) ._. Once_RB a_DT change_NN in_IN expression_NN of_IN the_DT 240_CD genes_NNS in_IN
          Table_NNP 3_CD have_VBP been_VBN validated_JJ ,_, similar_JJ analyses_NNS of_IN their_PRP$
          putative_JJ function_NN need_VBP to_TO be_VB made_VBN in_IN order_NN to_TO begin_VB to_TO
          address_VB what_WP role_NN the_DT genes_NNS play_VBP in_IN the_DT adaptive_JJ and_CC
          maladaptive_JJ response_NN to_TO nerve_NN injury_NN ._.
          Additional_JJ File_NNP 3_CD
          Summary_NNP of_IN expression_NN patterns_NNS and_CC functional_JJ roles_NNS of_IN
          uncharacterized_JJ nerve-injury_JJ regulated_VBN genes_NNS ._.
          Click_NNP here_RB for_IN file_NN
        
        
          Global_JJ changes_NNS in_IN transcription_NN
          The_DT 240_CD genes_NNS defined_VBN as_RB putatively_RB regulated_VBN
          (_( >_NN 1_CD ._. 5_LS -_: fold_VB ,_, P_NN <_NN 0_CD ._. 05_CD )_) within_IN the_DT DRG_NNP 3_CD days_NNS after_IN
          sciatic_JJ nerve_NN section_NN represent_VB 5_CD ._. 1_CD %_NN of_IN the_DT detected_VBN
          genes_NNS ,_, and_CC of_IN these_DT 2_CD ._. 8_CD %_NN are_VBP up-regulated_JJ and_CC 2_CD ._. 3_CD %_NN
          down-regulated_JJ (_( Figure_NN 6_CD A_DT )_) ._. These_DT genes_NNS were_VBD assigned_VBN
          into_IN functional_JJ classes_NNS and_CC characterized_VBN as_IN up-_NN and_CC
          down-regulated_JJ ._. Some_DT gene_NN classes_NNS are_VBP selectively_RB
          regulated_VBN after_IN axotomy_NN (_( Figure_NN 6_CD B_NNP )_) ._. Genes_NNP associated_VBN
          with_IN the_DT cell_NN cytoskeleton_NN ,_, positive_JJ and_CC negative_JJ
          regulators_NNS of_IN apoptosis_NNS as_RB well_RB as_IN immune_JJ markers_NNS tend_VBP to_TO
          be_VB up-regulated_JJ ,_, whereas_IN genes_NNS involved_VBN in_IN membrane_NN
          excitability_NN (_( ion_NN channels_NNS )_) or_CC neurotransmission_NN
          (_( neurotransmitters_NNS and_CC vesicle_NN trafficking_NN genes_NNS )_) tend_VBP to_TO
          be_VB down-regulated_JJ ._.
        
      
      
        Discussion_NNP
        Although_IN many_JJ studies_NNS have_VBP used_VBN microarray_NN technology_NN
        for_IN expression_NN profiling_VBG ,_, the_DT criteria_NNS for_IN determining_VBG
        putatively_RB regulated_VBN genes_NNS from_IN such_JJ analyses_NNS remain_VBP poorly_RB
        defined_VBN ,_, the_DT current_JJ standard_JJ being_NN a_DT >_NN 2_CD -_: fold_VB difference_NN
        in_IN replicate_VB arrays_NNS ._. Using_VBG Affymetrix_NNP high-density_JJ rat_NN
        oligonucleotide-array_JJ data_NNS from_IN control_NN (_( naïve_NN ,_,
        non-injured_JJ )_) and_CC experimental_JJ (_( axotomy_NN ,_, 3_CD day_NN post_NN
        peripheral_JJ nerve_NN injury_NN )_) DRGs_NNP ,_, and_CC comparing_VBG the_DT
        differences_NNS detected_VBD in_IN control_NN vs_NNS ._. control_NN and_CC control_NN vs_NNS ._.
        experimental_JJ arrays_NNS ,_, we_PRP have_VBP explored_JJ the_DT optimal_NN criteria_NNS
        for_IN minimizing_VBG the_DT false_JJ positive_JJ error_NN rate_NN ._. A_DT >_NN 2_CD -_: fold_VB
        criterion_NN alone_RB was_VBD found_VBN to_TO generate_VB a_DT substantial_JJ
        proportion_NN of_IN potential_JJ false_JJ positives_NNS ,_, while_IN also_RB
        excluding_VBG many_JJ putatively_RB regulated_VBN genes_NNS ._. Based_VBN on_IN
        significant_JJ difference_NN for_IN each_DT probe_NN set_VBN (_( P_NN <_NN 0_CD ._. 05_CD )_) ,_,
        109_CD genes_NNS differed_VBD in_IN the_DT control_NN vs_NNS ._. control_NN group_NN ,_, and_CC
        556_CD in_IN the_DT control_NN vs_NNS ._. experimental_JJ group_NN ,_, again_RB a_DT
        prohibitively_RB high_JJ false_JJ positive_JJ rate_NN (_( 20_CD %_NN )_) ._. However_RB ,_, a_DT
        combination_NN of_IN fold_VB and_CC significant_JJ difference_NN was_VBD found_VBN to_TO
        maximize_VB the_DT difference_NN between_IN control_NN vs_NNS ._. control_NN and_CC
        control_NN vs_NNS ._. experimental_JJ array_NN comparisons_NNS ._. Using_VBG
        >_NN 1_CD ._. 5_LS -_: fold_VB and_CC P_NN <_NN 0_CD ._. 05_CD ,_, 240_CD putatively_RB regulated_VBN
        genes_NNS were_VBD detected_VBN in_IN the_DT experimental_JJ group_NN compared_VBN with_IN
        only_RB 12_CD in_IN the_DT control_NN group_NN ,_, an_DT estimated_VBN error_NN rate_NN of_IN
        5_CD %_NN ._. If_IN fold_VB differences_NNS of_IN 1_CD ._. 25_CD to_TO 1_CD ._. 5_CD are_VBP included_VBN ,_, many_JJ
        more_RBR significantly_RB different_JJ genes_NNS are_VBP recruited_VBN (_( 219_CD in_IN
        the_DT experimental_JJ vs_NNS ._. 41_CD in_IN the_DT control_NN comparison_NN )_) reducing_VBG
        the_DT potential_JJ false_JJ negative_JJ rate_NN ._. At_IN the_DT same_JJ time_NN ,_, the_DT
        estimated_VBN false_JJ positive_JJ error_NN rate_NN rises_VBZ to_TO 11_CD ._. 5_LS %_NN ,_, still_RB
        lower_JJR than_IN the_DT 2_CD -_: fold_VB alone_RB error_NN ._. Producing_NNP a_DT reduction_NN in_IN
        false_JJ positive_NN without_IN also_RB producing_VBG false_JJ negative_JJ
        differences_NNS requires_VBZ the_DT use_NN both_DT of_IN fold_VB and_CC significant_JJ
        difference_NN ._. The_DT established_VBN 2_CD -_: fold_VB criterion_NN is_VBZ much_RB too_RB
        conservative_JJ ;_: when_WRB using_VBG replicate_VB arrays_NNS with_IN pooled_VBN
        samples_NNS from_IN multiple_JJ animals_NNS to_TO reduce_VB biological_JJ
        variation_NN ,_, it_PRP loses_VBZ over_IN 50_CD %_NN of_IN putatively_RB regulated_VBN genes_NNS
        and_CC fails_VBZ to_TO eliminate_VB false_JJ positives_NNS ._. The_DT very_RB high_JJ
        concordance_NN rate_NN found_VBD between_IN genes_NNS predicted_VBD from_IN the_DT
        array_NN analysis_NN to_TO be_VB regulated_VBN and_CC measurements_NNS of_IN mRNA_NN for_IN
        24_CD genes_NNS by_IN quantitative_JJ Northern_NNP slot_NN blots_NNS and_CC 
        in_IN situ_NN hybridization_NN ,_, validates_NNS
        utilization_NN of_IN a_DT two_CD dimensional_NN matrix_NN of_IN fold_VB and_CC
        significant_JJ difference_NN ._.
        One_CD problem_NN with_IN oligonucleotide_NN arrays_NNS is_VBZ sensitivity_NN ._.
        Some_DT groups_NNS of_IN transcripts_NNS ,_, particularly_RB GPCRs_NNP ,_, including_VBG
        the_DT opiate_NN receptors_NNS ,_, which_WDT are_VBP expressed_VBN in_IN the_DT DRG_NNP ,_, [_NN 14_CD
        ]_NN fall_NN below_IN the_DT microarray_NN detection_NN threshold_NN ._. Lack_NN of_IN
        sensitivity_NN may_MD result_VB from_IN technical_JJ issues_NNS such_JJ as_IN poor_JJ
        probe_NN performance_NN [_NN 11_CD ]_NN or_CC low_JJ copy_NN number_NN transcripts_NNS ._.
        Tissue_NNP heterogeneity_NN and_CC neuronal_NN subpopulation-restricted_JJ
        gene_NN expression_NN may_MD lower_VB the_DT concentration_NN of_IN a_DT transcript_NN
        in_IN the_DT total_JJ RNA_NNP sample_NN to_TO below_IN detection_NN threshold_NN [_NN 10_CD ]_NN
        ._.
        Recently_RB Xiao_NNP et_CC al_NN [_NN 9_CD ]_NN published_VBD a_DT study_NN using_VBG 7_CD ._. 5_CD K_NNP
        cDNA_NN arrays_NNS to_TO analyze_VB genes_NNS regulated_VBN in_IN the_DT DRG_NNP 2_CD ,_, 7_CD ,_, 14_CD
        and_CC 28_CD days_NNS following_VBG sciatic_JJ nerve_NN axotomy_NN ._. Of_IN the_DT genes_NNS
        listed_VBN in_IN Table_NNP 4_CD ,_, seven_CD were_VBD found_VBN in_IN both_DT studies_NNS
        (_( Peripheral_NNP Benzodiazepine_NNP receptor_NN ,_, 5_CD HT_NNP 3_CD ,_, Gadd_NNP 45_CD ,_, CLP_NNP 36_CD ,_,
        Lysozyme_NNP ,_, SNAP_NNP 25_CD and_CC VGF_NNP )_) ._. Of_IN those_DT genes_NNS whose_WP$ expression_NN
        was_VBD analyzed_VBN across_IN time_NN in_IN this_DT study_NN (_( Figure_NN 5_LS )_) two_CD ,_,
        Lysozyme_NNP and_CC SNAP_NNP 25_CD ,_, were_VBD also_RB detected_VBN by_IN Xiao_NNP et_CC al_NN [_NN 9_CD ]_NN
        ._. Both_DT genes_NNS show_VBP very_RB similar_JJ expression_NN patterns_NNS over_IN
        time_NN in_IN the_DT two_CD studies_NNS ._.
        In_IN a_DT different_JJ cDNA_NN array_NN study_NN ,_, also_RB recently_RB
        published_VBN ,_, 16_CD genes_NNS were_VBD identified_VBN to_TO be_VB regulated_VBN by_IN at_IN
        least_JJS 2_CD -_: fold_VB one_CD week_NN after_IN sciatic_JJ axotomy_NN [_NN 8_CD ]_NN ._. Of_IN
        these_DT ,_, seven_CD were_VBD also_RB identified_VBN by_IN our_PRP$ study_NN ._. Five_CD of_IN the_DT
        non-concordant_JJ genes_NNS were_VBD not_RB represented_VBN by_IN known_VBN probe_NN
        sets_NNS on_IN the_DT array_NN used_VBN here_RB ._. Others_NNS changed_VBN ,_, but_CC did_VBD not_RB
        reach_VB statistical_JJ significance_NN ,_, and_CC likely_RB represented_VBD
        differences_NNS in_IN regulation_NN levels_NNS relative_JJ to_TO the_DT time_NN
        points_NNS used_VBN (_( 1_CD week_NN as_IN opposed_VBN to_TO 3_CD days_NNS )_) ._. One_CD gene_NN
        verified_VBN in_IN this_DT study_NN ,_, the_DT small_JJ proline-rich_JJ protein_NN 1_CD A_DT
        (_( Table_NNP 2_LS )_) ,_, was_VBD characterized_VBN in_IN detail_NN by_IN Bonilla_NNP et_CC al_NN ,_,
        who_WP show_VBP that_IN it_PRP colocalizes_NNS with_IN filamentous_JJ actin_NN in_IN
        membrane_NN ruffles_NNS and_CC augments_NNS axonal_NN outgrowth_NN [_NN 8_CD ]_NN ._.
        Comparison_NNP of_IN the_DT global_JJ lists_NNS of_IN regulated_VBN genes_NNS
        between_IN this_DT study_NN and_CC other_JJ reports_NNS are_VBP complicated_VBN by_IN the_DT
        differing_VBG criteria_NNS used_VBN to_TO identify_VB regulated_VBN genes_NNS in_IN the_DT
        different_JJ studies_NNS ._. However_RB ,_, it_PRP is_VBZ encouraging_VBG to_TO note_VB that_IN
        a_DT reasonable_JJ number_NN of_IN genes_NNS have_VBP been_VBN cross_NN identified_VBN in_IN
        three_CD separate_JJ array_NN studies_NNS looking_VBG at_IN the_DT effects_NNS of_IN
        peripheral_JJ nerve_NN injury_NN on_IN dorsal_NN root_NN ganglion_NN gene_NN
        expression_NN ,_, pointing_VBG to_TO the_DT reliability_NN of_IN array_NN
        technologies_NNS across_IN differing_VBG platforms_NNS ._.
        Why_WRB is_VBZ the_DT number_NN of_IN genes_NNS regulated_VBN in_IN sensory_JJ neurons_NNS
        after_IN peripheral_JJ nerve_NN injury_NN so_RB large_JJ ?_. The_DT injury_NN
        constitutes_VBZ an_DT enormous_JJ stress_NN to_TO the_DT cell_NN and_CC also_RB
        deprives_VBZ it_PRP from_IN contact_NN with_IN its_PRP$ normal_JJ target-derived_JJ
        neurotrophic_JJ support_NN ._. Both_DT of_IN these_DT events_NNS represent_VBP
        perturbations_NNS from_IN normal_JJ cellular_JJ functioning_NN that_WDT require_VBP
        a_DT variety_NN of_IN compensatory_JJ responses_NNS ._. A_DT major_JJ issue_NN is_VBZ cell_NN
        survival_NN ._. Injured_NNP adult_NN DRG_NNP neurons_NNS do_VBP not_RB die_VB after_IN axonal_NN
        injury_NN [_NN 15_CD ]_NN as_IN a_DT result_NN of_IN the_DT upregulation_NN of_IN cell_NN
        survival_NN factors_NNS such_JJ as_IN the_DT small_JJ heat_NN shock_NN protein_NN HSP_NNP 27_CD
        [_NN 16_CD ]_NN ._. We_PRP now_RB find_VBP several_JJ genes_NNS that_WDT could_MD have_VB a_DT
        survival-promoting_JJ role_NN ,_, including_VBG the_DT peripheral_JJ
        benzodiazepine_NN receptor_NN ,_, whose_WP$ agonists_NNS are_VBP potent_JJ
        antiapoptotic_JJ compounds_NNS [_NN 17_CD ]_NN ,_, GADD_NNP 45_CD A_DT ,_, which_WDT maintains_VBZ
        genomic_JJ stability_NN and_CC appears_VBZ to_TO be_VB anti-apoptotic_JJ in_IN
        neurons_NNS after_IN ischemic_JJ damage_NN [_NN 18_CD ]_NN ,_, metallothionein_NN 1_CD L_NNP ,_,
        which_WDT is_VBZ a_DT free_JJ radical_JJ scavenger_NN [_NN 19_CD ]_NN ,_, GTP_NNP
        cyclohydrolase_NN 1_CD ,_, which_WDT is_VBZ obligatory_JJ for_IN the_DT actions_NNS of_IN
        NGF_NNP on_IN PC_NN 12_CD cells_NNS [_NN 20_CD ]_NN ,_, and_CC IES-JE_NNP (_( MCP-_NNP 1_LS )_) which_WDT
        attracts_VBZ macrophages_NNS ,_, which_WDT in_IN turn_NN have_VBP been_VBN reported_VBN to_TO
        have_VB a_DT role_NN in_IN neuronal_NN survival_NN [_NN 21_CD ]_NN ._.
        Neurons_NNP with_IN axons_NNS in_IN the_DT peripheral_JJ nervous_JJ system_NN can_MD
        successfully_RB regenerate_VB when_WRB injured_VBN [_NN 22_CD ]_NN ._. This_DT is_VBZ in_IN
        part_NN due_JJ to_TO an_DT environment_NN permissive_JJ for_IN axonal_NN growth_NN but_CC
        also_RB due_JJ to_TO the_DT upregulation_NN of_IN regeneration-associated_JJ
        genes_NNS (_( RAGs_NNP )_) which_WDT increase_VBP intrinsic_JJ growth_NN capacity_NN [_NN 23_CD
        ]_NN ._. Three_CD examples_NNS of_IN RAGs_NNP are_VBP GAP-_NNP 43_CD and_CC CAP-_NNP 23_CD [_NN 24_CD ]_NN and_CC
        sprp_NN 1_CD A_DT [_NN 8_CD ]_NN ._. We_PRP now_RB find_VBP several_JJ other_JJ potential_JJ
        candidates_NNS including_VBG ;_: α_NN 2_CD macroglobulin_NN ,_, CLP_NNP 36_CD ,_, and_CC VGF_NNP all_DT
        of_IN which_WDT have_VBP been_VBN described_VBN to_TO promote_VB neurite_NN outgrowth_NN
        or_CC interact_NN with_IN the_DT cytoskeleton_NN in_IN a_DT way_NN that_WDT may_MD promote_VB
        regeneration_NN (_( see_VB Table_NNP 4_CD [_NN additional_JJ file_NN 3_CD ]_NN for_IN
        references_NNS )_) ._. MMP_NNP 3_CD also_RB known_VBN as_IN 53_CD kD_NN polypeptide_NN ,_, transin_NN
        or_CC stromelysin-_NN 1_CD ,_, a_DT secreted_JJ protease_NN ,_, may_MD facilitate_VB
        neurite_NN growth_NN by_IN dissolving_VBG the_DT extracellular_NN matrix_NN of_IN
        the_DT basal_NN lamina_NN at_IN the_DT growing_VBG tip_NN of_IN the_DT axon_NN (_( see_VB Table_NNP
        4_CD for_IN references_NNS )_) ._.
        Sensory_NNP neurons_NNS react_VBP to_TO peripheral_JJ nerve_NN injury_NN by_IN
        increasing_VBG their_PRP$ excitability_NN ,_, changing_VBG their_PRP$ constitutive_JJ
        synaptic_JJ transmitter_NN profile_NN and_CC even_RB their_PRP$ synaptic_JJ
        contacts_NNS in_IN the_DT spinal_JJ cord_NN ._. Interestingly_RB ,_, an_DT analysis_NN of_IN
        the_DT functional_JJ classes_NNS of_IN the_DT genes_NNS differentially_RB
        expressed_VBD (_( Figure_NN 6_CD )_) reveals_VBZ the_DT contribution_NN that_IN
        alterations_NNS in_IN transcription_NN make_NN to_TO these_DT processes_NNS ._.
        Several_JJ of_IN these_DT changes_NNS are_VBP maladaptive_JJ in_IN the_DT sense_NN that_IN
        they_PRP contribute_VBP to_TO the_DT generation_NN of_IN the_DT abnormal_JJ
        sensations_NNS that_WDT constitute_VBP neuropathic_JJ pain_NN ,_, by_IN producing_VBG
        ectopic_JJ spontaneous_JJ activity_NN into_IN the_DT CNS_NNP ,_, altering_VBG
        synaptic_JJ drive_NN ,_, increasing_VBG excitability_NN and_CC diminishing_VBG
        inhibitory_NN action_NN in_IN the_DT dorsal_NN horn_NN of_IN the_DT spinal_JJ cord_NN ,_,
        and_CC by_IN making_VBG novel_NN synaptic_JJ contacts_NNS with_IN inappropriate_JJ
        neurons_NNS [_NN 1_CD 4_CD ]_NN ._. A_DT number_NN of_IN the_DT injury-regulated_JJ genes_NNS we_PRP
        describe_VBP here_RB may_MD contribute_VB directly_RB to_TO this_DT altered_JJ
        sensory_JJ processing_NN ;_: CB_NNP 1_CD receptor_NN ,_, VGF_NNP ,_, the_DT phospholemman_NN
        ion_NN channel_NN ,_, SNAP_NNP 25_CD A_DT ,_, endothelin-_NN 1_CD and_CC the_DT ligand-gated_JJ
        5_CD -_: HT_NNP 3_CD receptor_NN (_( Table_NNP 4_CD ,_, see_VBP additional_JJ file_NN 3_LS )_) ._. We_PRP have_VBP
        only_RB validated_JJ a_DT small_JJ fraction_NN of_IN the_DT putatively_RB regulated_VBN
        genes_NNS detected_VBN by_IN the_DT arrays_NNS ._. Our_PRP$ analysis_NN indicates_VBZ that_IN
        at_IN a_DT conservative_JJ estimate_NN over_IN two_CD hundred_CD genes_NNS (_( 240_CD
        genes_NNS ,_, >_NN 1_CD ._. 5_LS -_: fold_VB ,_, P_NN <_NN 0_CD ._. 05_CD )_) are_VBP regulated_VBN by_IN the_DT
        injury_NN ._. These_DT include_VBP genes_NNS of_IN a_DT number_NN of_IN distinct_JJ
        functional_JJ classes_NNS ,_, some_DT of_IN which_WDT appear_VBP to_TO change_VB in_IN a_DT
        uniform_NN way_NN ._. Ion_NNP channels_NNS and_CC neurotransmitter_NN related_VBD
        genes_NNS tend_VBP to_TO decrease_VB their_PRP$ expression_NN while_IN those_DT
        associated_VBN with_IN the_DT cytoskeleton_NN increase_NN ._. This_DT raises_VBZ the_DT
        possibility_NN that_IN numbers_NNS of_IN different_JJ genes_NNS may_MD be_VB
        regulated_VBN together_RB by_IN common_JJ changes_NNS in_IN signal_NN transduction_NN
        and_CC transcription_NN induced_VBN by_IN the_DT injury_NN ,_, and_CC contribute_VB in_IN
        this_DT way_NN to_TO the_DT coordinated_VBN changes_NNS that_WDT constitute_VBP the_DT
        axotomy_NN response_NN ._.
        Discovering_NNP and_CC validating_VBG regulated_VBN genes_NNS by_IN array_NN
        analysis_NN is_VBZ clearly_RB only_RB the_DT first_JJ step_NN in_IN elucidating_VBG
        their_PRP$ functional_JJ role_NN ._. An_DT evaluation_NN of_IN the_DT cellular_JJ
        localization_NN and_CC distribution_NN of_IN the_DT gene_NN product_NN as_RB well_RB
        as_IN loss_NN and_CC gain_NN of_IN function_NN manipulations_NNS 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN are_VBP required_VBN ._. Functional_NNP
        studies_NNS cannot_NN yet_RB be_VB performed_VBN at_IN a_DT high_JJ throughput_NN level_NN
        and_CC this_DT represents_VBZ one_CD of_IN the_DT major_JJ limiting_VBG factors_NNS in_IN
        analyzing_VBG the_DT large_JJ numbers_NNS of_IN candidate_NN genes_NNS identified_VBN
        by_IN microarray_NN analysis_NN ._. Elucidating_NNP the_DT specific_JJ role_NN of_IN
        genes_NNS regulated_VBN in_IN sensory_JJ neurons_NNS after_IN peripheral_JJ nerve_NN
        injury_NN will_MD provide_VB insight_NN though_IN into_IN many_JJ major_JJ
        biological_JJ issues_NNS including_VBG cell_NN survival_NN ,_, growth_NN ,_,
        intercellular_NN communication_NN and_CC the_DT factors_NNS that_WDT contribute_VBP
        to_TO sensory_JJ abnormalities_NNS ._. Microarray_NNP technology_NN provides_VBZ a_DT
        powerful_JJ tool_NN for_IN beginning_VBG this_DT analysis_NN in_IN a_DT high_JJ
        throughput_NN mode_NN by_IN revealing_VBG the_DT extent_NN of_IN change_NN in_IN
        neuronal_NN gene_NN expression_NN ._. Such_JJ analysis_NN requires_VBZ replicate_VB
        measures_NNS to_TO minimize_VB variability_NN ,_, calculation_NN of_IN fold_VB and_CC
        significant_JJ differences_NNS to_TO detect_VB regulated_VBN genes_NNS with_IN
        minimal_JJ false_JJ positive_JJ and_CC negative_JJ confounders_NNS and_CC
        validation_NN of_IN individual_JJ genes_NNS ._.
      
      
        Conclusions_NNP
        
        1_LS :_: A_DT comparison_NN of_IN two_CD naïve_NN (_( control_NN )_)
        triplicate_NN data_NNS sets_NNS allowed_VBD determination_NN of_IN the_DT inherent_JJ
        variation_NN present_JJ in_IN the_DT oligonucleotide_NN array_NN data_NNS ._.
        Analysis_NNP revealed_VBD a_DT relatively_RB high_JJ false_JJ positive_JJ error_NN
        rate_NN in_IN the_DT naïve_NN versus_CC axotomy_NN (_( experimental_JJ )_) comparisons_NNS
        (_( 16_CD %_NN )_) when_WRB using_VBG only_RB a_DT 2_CD -_: fold_VB criterion_NN for_IN regulated_VBN gene_NN
        detection_NN ._.
        
        2_LS :_: When_WRB statistical_JJ significance_NN (_( P_NN
        <_NN 0_CD ._. 05_CD )_) was_VBD combined_VBN with_IN a_DT fold_VB difference_NN of_IN greater_JJR
        than_IN 1_CD ._. 5_CD as_IN the_DT criteria_NNS for_IN detecting_VBG putatively_RB regulated_VBN
        genes_NNS ,_, not_RB only_RB was_VBD the_DT estimated_VBN false_JJ positive_JJ error_NN
        substantially_RB reduced_VBD (_( to_TO 5_CD %_NN )_) ,_, but_CC also_RB many_JJ more_JJR genes_NNS
        were_VBD identified_VBN compared_VBN with_IN the_DT established_VBN 2_CD -_: fold_VB
        criterion_NN ,_, in_IN the_DT naïve_NN versus_CC axotomy_NN comparison_NN (_( 240_CD as_IN
        opposed_VBN to_TO 178_CD genes_NNS )_) ._.
        
        3_LS :_: All_DT 240_CD genes_NNS displaying_VBG a_DT fold_VB
        change_NN of_IN greater_JJR than_IN 1_CD ._. 5_CD and_CC a_DT P-_NNP value_NN of_IN less_JJR than_IN 0_CD ._. 05_CD
        are_VBP listed_VBN ._.
        
        4_LS :_: To_TO validate_NN these_DT findings_NNS we_PRP
        performed_VBD quantitative_JJ triplicate_NN slot_NN blots_NNS for_IN 24_CD genes_NNS ,_,
        enabling_VBG a_DT direct_JJ comparison_NN between_IN the_DT statistically_RB
        analyzed_VBN array_NN data_NNS and_CC the_DT mRNA_NN measurements_NNS ._. These_DT
        comparisons_NNS show_VBP strong_JJ concordance_NN between_IN putative_JJ and_CC
        actual_JJ regulation_NN as_RB well_RB as_IN a_DT direct_JJ relationship_NN between_IN
        array_NN fold_VB change_NN and_CC mRNA_NN fold_VB change_NN ._.
        
        5_LS :_: Some_DT genes_NNS were_VBD further_RBR quantified_VBN
        across_IN a_DT time_NN course_NN of_IN 1_CD ,_, 3_CD ,_, 7_CD and_CC 14_CD days_NNS post_NN axotomy_NN ._.
        These_DT genes_NNS show_VBP diverse_JJ patterns_NNS of_IN regulation_NN in_IN response_NN
        to_TO nerve_NN injury_NN and_CC underlie_VB the_DT importance_NN of_IN including_VBG
        time_NN as_IN a_DT dimension_NN in_IN any_DT expression_NN profile_NN study_NN ._.
        
        6_CD :_: Genes_NNP detected_VBD from_IN the_DT arrays_NNS ,_, as_IN
        being_VBG likely_JJ to_TO be_VB regulated_VBN ,_, were_VBD assigned_VBN to_TO functional_JJ
        groups_NNS ._. These_DT data_NNS suggest_VBP the_DT reorganization_NN of_IN cell_NN
        structural_JJ components_NNS following_VBG peripheral_JJ nerve_NN injury_NN ,_,
        activation_NN of_IN genes_NNS expressed_VBN by_IN immune_JJ and_CC inflammatory_JJ
        cells_NNS ,_, and_CC a_DT down-regulation_JJ of_IN genes_NNS involved_VBN in_IN
        neurotransmission_NN ._.
      
      
        Methods_NNP
        
          Surgical_NNP procedures_NNS
          All_DT procedures_NNS were_VBD performed_VBN in_IN accordance_NN with_IN
          Massachusetts_NNP General_NNP Hospital_NNP animal_NN care_NN regulations_NNS ._.
          Adult_NNP male_JJ Sprague_NNP Dawley_NNP rats_NNS (_( 200_CD -_: 300_CD g_SYM )_) were_VBD
          anesthetized_JJ with_IN halothane_NN ._. For_IN the_DT sciatic_JJ nerve_NN
          transection_NN (_( axotomy_NN )_) ,_, the_DT left_NN sciatic_JJ nerve_NN was_VBD exposed_VBN
          at_IN the_DT mid_JJ thigh_NN level_NN ,_, ligated_JJ with_IN 3_CD /_NN 0_CD silk_NN and_CC
          sectioned_JJ distally_RB ._. The_DT wound_VBD was_VBD sutured_JJ in_IN two_CD layers_NNS ,_,
          and_CC the_DT animals_NNS were_VBD allowed_VBN to_TO recover_VB ._.
        
        
          Tissue_NNP and_CC RNA_NNP preparation_NN
          Animals_NNS were_VBD terminally_RB anesthetized_JJ with_IN CO_NNP 
          2_CD ,_, the_DT L_NNP 4_CD and_CC L_NNP 5_CD DRGs_NNP rapidly_RB
          removed_VBD ,_, and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. Total_NNP RNA_NNP was_VBD extracted_VBN
          from_IN homogenized_JJ DRG_NNP samples_NNS using_VBG acid_NN phenol_NN extraction_NN
          (_( TRIzol_NNP reagent_NN ,_, Gibco-_NNP BRL_NNP )_) ._. RNA_NNP concentration_NN was_VBD
          evaluated_VBN by_IN A_DT 
          260_CD measurement_NN and_CC quality_NN assessed_VBN
          by_IN electrophoresis_NNS on_IN a_DT 1_CD ._. 5_CD %_NN agarose_NN gel_NN ._. Each_DT RNA_NNP sample_NN
          used_VBN for_IN hybridization_NN of_IN each_DT array_NN was_VBD extracted_VBN from_IN
          rat_NN L_NNP 4_CD and_CC L_NNP 5_CD DRGs_NNP (_( 10_CD ganglia_NN pooled_VBN from_IN 5_CD animals_NNS ,_, per_IN
          sample_NN )_) ._.
        
        
          Microarray_NNP Analysis_NNP
          Affymetrix_NNP rat_NN genome_NN U_NNP 34_CD A_DT oligonucleotide_NN
          microarrays_NNS ,_, representing_VBG 8799_CD known_VBN transcripts_NNS and_CC
          expressed_VBD sequence_NN tags_NNS (_( ESTs_NNP )_) ,_, were_VBD used_VBN (_( Santa_NNP Clara_NNP ,_,
          CA_NNP http_NN :_: /_NN /_NN www_NN ._. affymetrix_NN ._. com_NN )_) ._. Oligonucleotides_NNP are_VBP
          arranged_VBN in_IN pairs_NNS corresponding_JJ to_TO different_JJ regions_NNS of_IN
          the_DT target_NN mRNA_NN with_IN multiple_JJ probe_NN pairs_NNS ._. Each_DT probe_NN
          pair_NN consists_VBZ of_IN a_DT 25_CD nucleotide_NN perfect_JJ match_NN (_( PM_NNP )_) to_TO
          the_DT target_NN region_NN coupled_VBN with_IN a_DT 25_CD -_: mer_NN with_IN a_DT single_JJ
          mismatch_NN (_( MM_NNP )_) at_IN the_DT 13_CD thnucleotide_NN ._. Transcript_NNP
          abundance_NN is_VBZ estimated_VBN by_IN analysis_NN of_IN signal_NN intensity_NN of_IN
          the_DT PM_NNP /_NN MM_NNP pairs_NNS ._. The_DT arrays_NNS are_VBP hybridized_JJ with_IN
          biotin-labeled_JJ cRNA_NN ,_, prepared_VBN as_IN per_IN standard_JJ Affymetrix_NNP
          protocol_NN ._. Briefly_NNP ,_, total_JJ RNA_NNP (_( 8_CD μg_NN )_) from_IN DRGs_NNP was_VBD reverse_VB
          transcribed_JJ using_VBG an_DT oligo-d_JJ T_NN primer_NN coupled_VBN to_TO a_DT T_NN 7_CD RNA_NNP
          polymerase_NN binding_JJ site_NN ._. Double-stranded_NNP cDNA_NN was_VBD made_VBN
          and_CC biotinylated-c_JJ RNA_NNP synthesized_JJ using_VBG T_NN 7_CD polymerase_NN ._.
          The_DT cRNA_NN was_VBD hybridized_JJ for_IN 16_CD hours_NNS to_TO an_DT array_NN ,_,
          followed_VBN by_IN binding_VBG with_IN a_DT streptavidin-conjugated_JJ
          fluorescent_NN marker_NN ,_, and_CC then_RB incubated_JJ with_IN a_DT polyclonal_NN
          anti-streptavidin_JJ antibody_NN coupled_VBN to_TO phycoerythrin_NN as_IN an_DT
          amplification_NN step_NN ._. Following_VBG washing_VBG ,_, the_DT chips_NNS were_VBD
          scanned_JJ with_IN a_DT Hewlett-_NNP Packard_NNP GeneArray_NNP laser_NN scanner_NN
          and_CC data_NNS analyzed_VBD using_VBG GeneChip_NNP software_NN ._. External_NNP
          standards_NNS were_VBD included_VBN to_TO control_VB for_IN hybridization_NN
          efficiency_NN and_CC sensitivity_NN ._.
          Hybridization_NNP levels_NNS for_IN each_DT species_NNS of_IN mRNA_NN detected_VBD
          on_IN the_DT arrays_NNS are_VBP expressed_VBN by_IN intensity_NN (_( signal_NN )_) and_CC as_IN
          present_JJ (_( P_NN )_) ,_, marginal_JJ (_( M_NNP )_) or_CC absent_JJ (_( A_DT )_) calls_VBZ ,_, calculated_VBN
          by_IN Affymetrix_NNP software_NN (_( MAS_NNP 5_CD ._. 0_CD ,_, α_NN 1_CD =_SYM 0_CD ._. 04_CD α_NN 2_CD =_SYM 0_CD ._. 06_CD )_) ._. To_TO
          normalize_VB the_DT array_NN data_NN standard_JJ Affymetrix_NNP protocols_NNS
          were_VBD employed_VBN ,_, each_DT array_NN was_VBD scaled_VBN to_TO a_DT target_NN signal_NN
          of_IN 2500_CD across_IN all_DT probe_NN sets_NNS (_( MAS_NNP 5_CD ._. 0_CD )_) ._.
          The_DT arrays_NNS were_VBD grouped_VBN for_IN two_CD comparisons_NNS :_: two_CD
          triplicate_NN sets_NNS of_IN naïve_NN data_NNS compared_VBN with_IN one_CD another_DT ,_,
          and_CC one_CD triplicate_NN naïve_NN set_VBN compared_VBN with_IN one_CD triplicate_NN
          post-axotomy_JJ set_VBN ._. The_DT individual_JJ naïve_NN arrays_NNS included_VBN in_IN
          each_DT triplicate_NN set_VBN were_VBD picked_VBN randomly_RB ._. A_DT probe_NN set_VBN was_VBD
          determined_VBN undetected_JJ if_IN it_PRP received_VBD an_DT A_DT call_NN in_IN all_DT of_IN
          the_DT six_CD arrays_NNS involved_VBN in_IN the_DT comparison_NN ._. Detected_NNP were_VBD
          Present_VB or_CC Marginal_JJ by_IN MAS_NNP 5_CD ._. 0_CD in_IN at_IN least_JJS one_CD array_NN for_IN
          each_DT analysis_NN ._. Mean_VB signal_NN and_CC standard_JJ deviation_NN were_VBD
          calculated_VBN for_IN each_DT detected_VBN probe_NN set_VBN ._. The_DT p-value_JJ for_IN
          rejecting_VBG the_DT null_NN hypothesis_NNS that_IN the_DT mean_NN signals_NNS were_VBD
          equal_JJ between_IN the_DT two_CD triplicate_NN sets_NNS was_VBD calculated_VBN
          using_VBG an_DT unpaired_JJ ,_, two-tailed_JJ t-test_JJ for_IN independent_JJ
          samples_NNS with_IN unequal_JJ variance_NN (_( Satterthwaite_NNP 's_POS method_NN )_) ._.
          Fold-differences_NNP between_IN the_DT mean_NN signals_NNS (_( A_DT and_CC B_NNP )_) in_IN
          the_DT two_CD triplicate_NN sets_NNS were_VBD calculated_VBN as_IN max_NN (_( A_DT ,_, B_NNP )_) /_NN
          min_NN (_( A_DT ,_, B_NNP )_) with_IN down_RB regulation_NN relative_JJ to_TO naïve_NN
          expressed_VBD as_IN negative_NN ._.
        
        
          cDNA_NN Probe_NNP production_NN
          To_TO generate_VB specific_JJ probes_NNS for_IN Northern_NNP blot_NN
          hybridization_NN experiments_NNS ,_, primers_NNS based_VBN on_IN the_DT rat_NN
          accession_NN number_NN provided_VBN by_IN Affymetrix_NNP were_VBD designed_VBN ,_,
          primer_NN pairs_NNS were_VBD chosen_VBN using_VBG the_DT Primer_NNP 3_CD software_NN
          http_NN :_: /_NN /_NN www-genome_JJ ._. wi_NN ._. mit_NN ._. edu_NN /_NN from_IN the_DT 1000_CD most_JJS 3_CD '_POS
          nucleotides_NNS within_IN each_DT accession_NN sequence_NN ._. PCR_NNP was_VBD
          performed_VBN on_IN cDNA_NN reverse_NN transcribed_JJ from_IN total_JJ RNA_NNP ,_,
          extracted_VBN from_IN lumbar_NN DRGs_NNP ,_, using_VBG poly-d_JJ T_NN as_IN a_DT primer_NN to_TO
          obtain_VB cDNA_NN fragments_NNS (_( 141_CD to_TO 596_CD bp_NN )_) ._. These_DT fragments_NNS
          were_VBD subsequently_RB cloned_VBN into_IN the_DT PCRII_NNP vector_NN (_( TA_NNP
          cloning_VBG Kit_NNP ,_, Invitrogen_NNP )_) and_CC the_DT identity_NN of_IN each_DT was_VBD
          confirmed_VBN by_IN sequencing_VBG in_IN both_DT directions_NNS ._. These_DT cDNAs_NNS
          were_VBD gel-purified_JJ and_CC used_VBN to_TO produce_VB 32_CD P-_NNP labeled_VBD cDNA_NN
          probes_NNS (_( Prime-_NNP It_PRP kit_NN ,_, Stratagene_NNP )_) ._.
        
        
          Northern_JJ blot_NN analysis_NN
          Total_NNP RNA_NNP was_VBD size_NN separated_VBN by_IN electrophoresis_NNS on_IN a_DT
          1_CD ._. 5_CD %_NN agarose_NN /_NN formaldehyde_NN gel_NN (_( 10_CD μg_NN of_IN total_JJ RNA_NNP per_IN
          lane_NN )_) and_CC transferred_VBN to_TO a_DT Hybond_NNP N_NNP +_NN nylon_NN membrane_NN ._.
          Membranes_NNP were_VBD hybridized_JJ with_IN labeled-probes_JJ (_( see_VB above_IN )_)
          in_IN ExpressHyb_NNP (_( Clontech_NNP )_) overnight_JJ at_IN 65_CD °_NN C_NNP ,_, washed_VBN and_CC
          exposed_VBN to_TO X-_NNP ray_NN film_NN with_IN an_DT intensifying_VBG screen_NN at_IN
          -_: 80_CD °_NN C_NNP ._.
        
        
          Slot_NNP Blots_NNP
          Total_NNP RNA_NNP (_( 1_CD ._. 25_CD μg_NN )_) was_VBD directly_RB transferred_VBN to_TO Hybond_NNP
          N_NNP +_NN nylon_NN membrane_NN under_IN vacuum_NN using_VBG a_DT Hoefer_NNP PR_NNP 648_CD slot_NN
          blot_NN apparatus_NN (_( Amersham_NNP Pharmacia_NNP Biotech_NNP )_) as_IN described_VBN
          in_IN [_NN 25_CD ]_NN ._. The_DT slot_NN blots_NNS were_VBD produced_VBN in_IN batches_NNS of_IN
          ten_CD from_IN a_DT relevant_JJ master_NN mix_NN and_CC probed_JJ with_IN the_DT same_JJ
          cDNA_NN under_IN the_DT same_JJ conditions_NNS as_IN described_VBN for_IN Northern_NNP
          blot_NN analysis_NN ._. Levels_NNP of_IN hybridization_NN were_VBD quantified_VBN
          using_VBG the_DT 24450_CD phosphorimager_NN system_NN (_( Molecular_NNP
          Dynamics_NNP ,_, Sunnyvale_NNP CA_NNP ._. )_) ._. One_CD of_IN the_DT blots_NNS in_IN each_DT batch_NN
          was_VBD probed_JJ for_IN cyclophilin_NN to_TO act_VB as_IN a_DT loading_NN control_NN ._.
          The_DT other_JJ nine_CD blots_NNS were_VBD used_VBN to_TO measure_VB the_DT expression_NN
          levels_NNS of_IN individual_JJ genes_NNS ._. Loading_NNP levels_NNS between_IN
          samples_NNS on_IN each_DT blot_NN were_VBD normalized_JJ using_VBG the_DT
          cyclophilin_NN levels_NNS from_IN the_DT control_NN blot_NN ._.
        
        
          Isotopic_NNP in_IN situHybridization_NN
          DRGs_NNP were_VBD rapidly_RB removed_VBN ,_, embedded_VBN in_IN OCT_NNP (_( Tissue_NNP
          Tek_NNP )_) and_CC frozen_VBN ._. Sections_NNP were_VBD cut_VBN serially_RB at_IN 6_CD μm_NN ._.
          Isotopic-_NNP 
          in_IN situ_NN hybridization_NN was_VBD carried_VBN
          out_IN using_VBG forty-eight_JJ base_NN pair_NN oligonucleotide_NN probes_NNS ,_,
          designed_VBN to_TO have_VB 50_CD %_NN G-C_NNP content_NN and_CC be_VB complementary_JJ to_TO
          the_DT mRNAs_NNS whose_WP$ accession_NN numbers_NNS were_VBD provided_VBN by_IN
          Affymetrix_NNP ._. Probes_NNP were_VBD 3_CD '_POS -_: end_NN labeled_VBN with_IN 35_CD S_NNP or_CC
          33_CD P-_NNP dATP_NN using_VBG a_DT terminal_NN transferase_NN reaction_NN and_CC
          hybridization_NN carried_VBD out_IN [_NN 26_CD ]_NN ._. Autoradiograms_NNP were_VBD
          generated_VBN by_IN dipping_VBG slides_NNS in_IN NTB_NNP 2_CD nuclear_JJ track_NN
          emulsion_NN and_CC storing_VBG in_IN the_DT dark_NN at_IN 4_CD °_NN C_NNP ._. Sections_NNP were_VBD
          exposed_VBN for_IN 1_CD -_: 8_CD weeks_NNS (_( depending_VBG on_IN the_DT abundance_NN of_IN
          transcript_NN )_) ,_, developed_VBN ,_, fixed_VBN and_CC viewed_VBN under_IN darkfield_NN
          using_VBG a_DT fiber-optic_JJ darkfield_NN stage_NN adapter_NN (_( MVI_NNP )_) ._.
          Controls_NNP to_TO confirm_VB specificity_NN of_IN oligonucleotide_NN probes_NNS
          included_VBD hybridization_NN of_IN sections_NNS with_IN labeled_VBN probe_NN
          with_IN a_DT 1_CD ,_, 000_CD -_: fold_VB excess_NN of_IN cold_JJ probe_NN or_CC labeled_VBN probe_NN
          with_IN a_DT 1_CD ,_, 000_CD -_: fold_VB excess_NN of_IN another_DT ,_, dissimilar_JJ cold_JJ
          probe_NN of_IN the_DT same_JJ length_NN and_CC similar_JJ G-C_NNP content_NN ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        MC_NNP carried_VBD out_IN array_NN probe_NN preparation_NN ,_, slot_NN blot_NN
        analysis_NN and_CC northern_JJ analysis_NN ,_, participated_VBD in_IN the_DT design_NN
        of_IN the_DT study_NN and_CC drafted_VBD the_DT manuscript_NN ._. KB_NNP carried_VBD out_IN
        northern_JJ analysis_NN and_CC data_NNS preparation_NN ,_, participated_VBD in_IN the_DT
        design_NN of_IN the_DT study_NN and_CC drafted_VBD the_DT manuscript_NN ._. LK_NNP carried_VBD
        out_IN in_IN situ_NN hybridization_NN and_CC participated_VBD in_IN the_DT design_NN of_IN
        the_DT study_NN ._. RSG_NNP carried_VBD out_IN statistical_JJ data_NNS analysis_NN and_CC
        functional_JJ group_NN analysis_NN and_CC participated_VBD in_IN the_DT design_NN of_IN
        the_DT study_NN ._. DD_NNP '_POS U_NNP participated_VBD in_IN data_NNS preparation_NN and_CC in_IN the_DT
        design_NN of_IN the_DT study_NN ._. AA_NN and_CC JS_NNP carried_VBD out_IN tissue_NN
        preparation_NN ._. JWM_NNP participated_VBD in_IN data_NNS preparation_NN ._. REP_NNP
        participated_VBD in_IN the_DT design_NN of_IN the_DT study_NN ._. CJW_NNP conceived_VBD the_DT
        study_NN and_CC participated_VBD in_IN its_PRP$ design_NN and_CC coordination_NN ._.
      
    
  
